Home Health Care News September 21, 2021
Andrew Donlan

Walgreens Boots Alliance (Nasdaq: WBA) plans to invest $970 million in Shields Health Solutions, which aids both hospitals and health systems with specialty pharmacy services.

It’s another major move for Walgreens, which is trying to position itself as an all-encompassing health care behemoth prepared for the sector’s near- and long-term trends.

The deal, which is set to close in February of 2022, would give Walgreens a 71% stake in the Massachusetts-based Shields, with an option to acquire the remaining portion of the company thereafter.

Walgreens first took interest in Shields when it made a minority investment in the company in 2019.

Similar to its $1 billion investment in the value-based primary care provider VillageMD in 2020, the investment in Shields...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Investments, Pharma, Pharma / Biotech, Provider, Trends
Daily Battle To Find Drugs Amid Shortages, England’s Pharmacists Say
Sanofi pays $1.2B to partner with Novavax on COVID-19 vaccine
FTC Puts Pharmacy Benefit Managers, Private Equity in the Crosshairs
CMS Guidance on IRA Price Negotiation: Part 2
STAT+: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

Share This Article